MINNEAPOLIS--(BUSINESS WIRE)-- Purilogics, a Donaldson Life Sciences business specializing in biopharmaceutical membrane chromatography development, today announced the availability of its first ...
W. L. Gore & Associates, Inc. ("Gore"), a global materials science company, is advancing the field of membrane chromatography through the development of new affinity membrane devices in collaboration ...
Biologics manufacturers are under increasing pressure to reduce production costs. This is a key driver for moving to continuous processing, which maximizes productivity while minimizing footprint.
Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies that help to improve patient outcomes with safer and more effective production of ...
The successful application of RNA therapies to rare diseases, neurological disorders, and other conditions as well as the plethora of biopharmaceutical companies developing new RNA-based therapeutics, ...
Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (“Delta Precision”), a ...
According to MarketsandMarkets™, the Preparative and Process Chromatography Market is projected to grow from about USD 14.32 billion in 2026 to USD 21.50 billion by 2031, at a CAGR of 8.2%.
Top articles include a new “GC Connections” article on maintenance practices for modern capillary gas chromatography (GC) systems, an interview on rapid per- and polyfluoralkyl substances (PFAS) ...
“We selected the Purexa NAEX membrane chromatography products for our initial expansion into manufacturing-grade offerings due to their broad applicability,” said Jin Zhou, Director of Purilogics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results